Monday, May 25, 2026

One-Third of Korea’s Top CEOs Set to Step Down by March 2025

One-third of top Korean CEOs will see term expirations by March 2025, with significant turnover in banking and energy sectors.

President Lee Questions Rodong Sinmun Ban, Asking If Government Treats Citizens As Vulnerable To Red Propaganda

President Lee Jae Myung advocates for public access to North Korea's Rodong Sinmun, questioning the rationale behind restrictions.

SK Hynix to Launch ADR on U.S. Stock Market: What This Means for AI Semiconductor Dominance in 2026

SK Hynix plans to list American Depositary Receipts on the U.S. market to fund advanced memory production and AI semiconductor growth.

Tag: Graves' disease

Imeroprubart vs. Batoclimab: Which Treatment Will Revolutionize Graves’ Disease Management?

HanAll Biopharma's Imeroprubart targets Graves' disease, showing promise with IgG suppression and user-friendly auto-injector delivery.

Top News

- Our Sponsors Ad -

Follow us